{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T05:40:04Z","timestamp":1793338804940,"version":"4.5.0"},"reference-count":115,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2025,5,30]],"date-time":"2025-05-30T00:00:00Z","timestamp":1748563200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,5,30]],"date-time":"2025-05-30T00:00:00Z","timestamp":1748563200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100000050","name":"NHLBI","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Heart Fail Rev"],"DOI":"10.1007\/s10741-025-10528-9","type":"journal-article","created":{"date-parts":[[2025,5,30]],"date-time":"2025-05-30T00:24:00Z","timestamp":1748564640000},"page":"1045-1059","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Sex differences in the presentation, pathophysiology, and prognosis of heart failure with preserved ejection fraction"],"prefix":"10.1007","volume":"30","author":[{"given":"Imo A.","family":"Ebong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmad","family":"Gill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Duke","family":"Appiah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rina","family":"Mauricio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,30]]},"reference":[{"issue":"18","key":"10528_CR1","doi-asserted-by":"publisher","first-page":"1810","DOI":"10.1016\/j.jacc.2023.01.049","volume":"81","author":"BA Borlaug","year":"2023","unstructured":"Borlaug BA, Sharma K, Shah SJ, Ho JE (2023) Heart failure with preserved ejection fraction: JACC scientific statement. J Am Coll Cardiol 81(18):1810\u20131834. https:\/\/doi.org\/10.1016\/j.jacc.2023.01.049","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"10528_CR2","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1161\/circulationaha.116.021884","volume":"134","author":"SJ Shah","year":"2016","unstructured":"Shah SJ, Kitzman DW, Borlaug BA et al (2016) Phenotype-specific treatment of heart failure with preserved ejection fraction: a multiorgan roadmap. Circulation 134(1):73\u201390. https:\/\/doi.org\/10.1161\/circulationaha.116.021884","journal-title":"Circulation"},{"issue":"5","key":"10528_CR3","doi-asserted-by":"publisher","DOI":"10.1161\/jaha.120.018574","volume":"10","author":"Y Sotomi","year":"2021","unstructured":"Sotomi Y, Hikoso S, Nakatani D et al (2021) Sex differences in heart failure with preserved ejection fraction. J Am Heart Assoc 10(5):e018574. https:\/\/doi.org\/10.1161\/jaha.120.018574","journal-title":"J Am Heart Assoc"},{"issue":"8","key":"10528_CR4","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1139\/cjpp-2023-0403","volume":"102","author":"Y Smereka","year":"2024","unstructured":"Smereka Y, Ezekowitz JA (2024) HFpEF and sex: understanding the role of sex differences. Can J Physiol Pharmacol 102(8):465\u2013475. https:\/\/doi.org\/10.1139\/cjpp-2023-0403","journal-title":"Can J Physiol Pharmacol"},{"issue":"2","key":"10528_CR5","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1161\/circulationaha.118.034271","volume":"138","author":"AL Beale","year":"2018","unstructured":"Beale AL, Meyer P, Marwick TH, Lam CSP, Kaye DM (2018) Sex differences in cardiovascular pathophysiology: why women are overrepresented in heart failure with preserved ejection fraction. Circulation 138(2):198\u2013205. https:\/\/doi.org\/10.1161\/circulationaha.118.034271","journal-title":"Circulation"},{"issue":"9","key":"10528_CR6","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.1016\/j.jacc.2019.12.049","volume":"75","author":"AR Sabbatini","year":"2020","unstructured":"Sabbatini AR, Kararigas G (2020) Menopause-related estrogen decrease and the pathogenesis of HFpEF: JACC review topic of the week. J Am Coll Cardiol 75(9):1074\u20131082. https:\/\/doi.org\/10.1016\/j.jacc.2019.12.049","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"10528_CR7","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1186\/s12884-024-06402-5","volume":"24","author":"SU Lee","year":"2024","unstructured":"Lee SU, Park JY, Hong S et al (2024) Risk factors for pregnancy-associated heart failure with preserved ejection fraction and adverse pregnancy outcomes: a cross-sectional study. BMC Pregnancy Childbirth 24(1):211. https:\/\/doi.org\/10.1186\/s12884-024-06402-5","journal-title":"BMC Pregnancy Childbirth"},{"issue":"2","key":"10528_CR8","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.cardfail.2020.12.020","volume":"27","author":"JE Briller","year":"2021","unstructured":"Briller JE, Mogos MF, Muchira JM, Piano MR (2021) Pregnancy associated heart failure with preserved ejection fraction: risk factors and maternal morbidity. J Card Fail 27(2):143\u2013152. https:\/\/doi.org\/10.1016\/j.cardfail.2020.12.020","journal-title":"J Card Fail"},{"issue":"1","key":"10528_CR9","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.hfc.2018.08.002","volume":"15","author":"A Tibrewala","year":"2019","unstructured":"Tibrewala A, Yancy CW (2019) Heart failure with preserved ejection fraction in women. Heart Fail Clin 15(1):9\u201318. https:\/\/doi.org\/10.1016\/j.hfc.2018.08.002","journal-title":"Heart Fail Clin"},{"issue":"3","key":"10528_CR10","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1056\/NEJMoa052256","volume":"355","author":"TE Owan","year":"2006","unstructured":"Owan TE, Hodge DO, Herges RM, Jacobsen SJ, Roger VL, Redfield MM (2006) Trends in prevalence and outcome of heart failure with preserved ejection fraction. New Engl J Med 355(3):251\u2013259. https:\/\/doi.org\/10.1056\/NEJMoa052256","journal-title":"New Engl J Med"},{"issue":"10","key":"10528_CR11","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1001\/jama.2023.2020","volume":"329","author":"MM Redfield","year":"2023","unstructured":"Redfield MM, Borlaug BA (2023) Heart failure with preserved ejection fraction: a review. JAMA 329(10):827\u2013838. https:\/\/doi.org\/10.1001\/jama.2023.2020","journal-title":"JAMA"},{"key":"10528_CR12","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.ijcard.2020.01.003","volume":"304","author":"CJ Pepine","year":"2020","unstructured":"Pepine CJ, Merz CNB, El Hajj S et al (2020) Heart failure with preserved ejection fraction: similarities and differences between women and men. Int J Cardiol 304:101\u2013108. https:\/\/doi.org\/10.1016\/j.ijcard.2020.01.003","journal-title":"Int J Cardiol"},{"key":"10528_CR13","doi-asserted-by":"publisher","unstructured":"Pandey A, Omar W, Ayers C et al (2018) Sex and race differences in lifetime risk of heart failure with preserved ejection fraction and heart failure with reduced ejection fraction. Circulation 137(17):1814-1823. https:\/\/doi.org\/10.1161\/circulationaha.117.031622","DOI":"10.1161\/circulationaha.117.031622"},{"issue":"2","key":"10528_CR14","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1080\/00325481.2020.1842621","volume":"133","author":"PP Toth","year":"2021","unstructured":"Toth PP, Gauthier D (2021) Heart failure with preserved ejection fraction: disease burden for patients, caregivers, and the health-care system. Postgrad Med 133(2):140\u2013145. https:\/\/doi.org\/10.1080\/00325481.2020.1842621","journal-title":"Postgrad Med"},{"key":"10528_CR15","doi-asserted-by":"publisher","unstructured":"Dewan P, R\u00f8rth R, Raparelli V et al (2019) Sex-related differences in heart failure with preserved ejection fraction. Circ Heart Fail 12(12):e006539. https:\/\/doi.org\/10.1161\/circheartfailure.119.006539","DOI":"10.1161\/circheartfailure.119.006539"},{"issue":"8","key":"10528_CR16","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1016\/j.amjcard.2005.11.042","volume":"97","author":"A Deswal","year":"2006","unstructured":"Deswal A, Bozkurt B (2006) Comparison of morbidity in women versus men with heart failure and preserved ejection fraction. Am J Cardiol 97(8):1228\u20131231. https:\/\/doi.org\/10.1016\/j.amjcard.2005.11.042","journal-title":"Am J Cardiol"},{"issue":"5","key":"10528_CR17","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1161\/circheartfailure.112.970061","volume":"5","author":"CS Lam","year":"2012","unstructured":"Lam CS, Carson PE, Anand IS et al (2012) Sex differences in clinical characteristics and outcomes in elderly patients with heart failure and preserved ejection fraction: the Irbesartan in heart failure with preserved ejection fraction (I-PRESERVE) trial. Circ Heart Fail 5(5):571\u2013578. https:\/\/doi.org\/10.1161\/circheartfailure.112.970061","journal-title":"Circ Heart Fail"},{"issue":"11","key":"10528_CR18","doi-asserted-by":"publisher","first-page":"1785","DOI":"10.1016\/j.amjcard.2017.02.045","volume":"119","author":"WT O'Neal","year":"2017","unstructured":"O'Neal WT, Sandesara P, Hammadah M et al (2017) Gender differences in the risk of adverse outcomes in patients with atrial fibrillation and heart failure with preserved ejection fraction. Am J Cardiol 119(11):1785\u20131790. https:\/\/doi.org\/10.1016\/j.amjcard.2017.02.045","journal-title":"Am J Cardiol"},{"key":"10528_CR19","doi-asserted-by":"publisher","unstructured":"Eaton CB, Pettinger M, Rossouw J et al (2016) Risk factors for incident hospitalized heart failure with preserved versus reduced ejection fraction in a multiracial cohort of postmenopausal women. Circ Heart Fail 9(10). https:\/\/doi.org\/10.1161\/circheartfailure.115.002883","DOI":"10.1161\/circheartfailure.115.002883"},{"issue":"1","key":"10528_CR20","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1161\/circulationaha.117.027551","volume":"138","author":"PP Chang","year":"2018","unstructured":"Chang PP, Wruck LM, Shahar E et al (2018) Trends in hospitalizations and survival of acute decompensated heart failure in four US communities (2005-2014): ARIC study community surveillance. Circulation 138(1):12\u201324. https:\/\/doi.org\/10.1161\/circulationaha.117.027551","journal-title":"Circulation"},{"issue":"2","key":"10528_CR21","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1002\/clc.23321","volume":"43","author":"B Upadhya","year":"2020","unstructured":"Upadhya B, Kitzman DW (2020) Heart failure with preserved ejection fraction: new approaches to diagnosis and management. Clin Cardiol 43(2):145\u2013155. https:\/\/doi.org\/10.1002\/clc.23321","journal-title":"Clin Cardiol"},{"issue":"1","key":"10528_CR22","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1161\/circheartfailure.110.957480","volume":"4","author":"DS Lee","year":"2011","unstructured":"Lee DS, Gona P, Albano I et al (2011) A systematic assessment of causes of death after heart failure onset in the community: impact of age at death, time period, and left ventricular systolic dysfunction. Circ Heart Fail 4(1):36\u201343. https:\/\/doi.org\/10.1161\/circheartfailure.110.957480","journal-title":"Circ Heart Fail"},{"key":"10528_CR23","doi-asserted-by":"publisher","unstructured":"Goyal P, Paul T, Almarzooq ZI et al (2017) Sex- and race-related differences in characteristics and outcomes of hospitalizations for heart failure with preserved ejection fraction. J Am Heart Assoc 6(4). https:\/\/doi.org\/10.1161\/jaha.116.003330","DOI":"10.1161\/jaha.116.003330"},{"issue":"1","key":"10528_CR24","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1038\/s41598-018-19507-7","volume":"8","author":"F Duca","year":"2018","unstructured":"Duca F, Zotter-Tufaro C, Kammerlander AA et al (2018) Gender-related differences in heart failure with preserved ejection fraction. Sci Rep 8(1):1080. https:\/\/doi.org\/10.1038\/s41598-018-19507-7","journal-title":"Sci Rep"},{"issue":"6","key":"10528_CR25","doi-asserted-by":"publisher","first-page":"1839","DOI":"10.1053\/j.jvca.2020.07.016","volume":"35","author":"PS Pagel","year":"2021","unstructured":"Pagel PS, Tawil JN, Boettcher BT et al (2021) Heart failure with preserved ejection fraction: a comprehensive review and update of diagnosis, pathophysiology, treatment, and perioperative implications. J Cardiothorac Vasc Anesth 35(6):1839\u20131859. https:\/\/doi.org\/10.1053\/j.jvca.2020.07.016","journal-title":"J Cardiothorac Vasc Anesth"},{"issue":"1","key":"10528_CR26","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1002\/ejhf.1029","volume":"20","author":"TM Gorter","year":"2018","unstructured":"Gorter TM, van Veldhuisen DJ, Bauersachs J et al (2018) Right heart dysfunction and failure in heart failure with preserved ejection fraction: mechanisms and management. Position statement on behalf of the Heart Failure Association of the European Society of Cardiology. Eur J Heart Fail 20(1):16\u201337. https:\/\/doi.org\/10.1002\/ejhf.1029","journal-title":"Eur J Heart Fail"},{"issue":"48","key":"10528_CR27","doi-asserted-by":"publisher","first-page":"3452","DOI":"10.1093\/eurheartj\/ehu193","volume":"35","author":"V Melenovsky","year":"2014","unstructured":"Melenovsky V, Hwang SJ, Lin G, Redfield MM, Borlaug BA (2014) Right heart dysfunction in heart failure with preserved ejection fraction. Eur Heart J 35(48):3452\u20133462. https:\/\/doi.org\/10.1093\/eurheartj\/ehu193","journal-title":"Eur Heart J"},{"issue":"6","key":"10528_CR28","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1016\/j.jacc.2023.05.010","volume":"82","author":"RM Inciardi","year":"2023","unstructured":"Inciardi RM, Abanda M, Shah AM et al (2023) Right ventricular function and pulmonary coupling in patients with heart failure and preserved ejection fraction. J Am Coll Cardiol 82(6):489\u2013499. https:\/\/doi.org\/10.1016\/j.jacc.2023.05.010","journal-title":"J Am Coll Cardiol"},{"issue":"5","key":"10528_CR29","doi-asserted-by":"publisher","first-page":"451","DOI":"10.2217\/fca-2017-0023","volume":"13","author":"S Carbone","year":"2017","unstructured":"Carbone S, Popovic D, Lavie CJ, Arena R (2017) Obesity, body composition and cardiorespiratory fitness in heart failure with preserved ejection fraction. Future Cardiol 13(5):451\u2013463. https:\/\/doi.org\/10.2217\/fca-2017-0023","journal-title":"Future Cardiol"},{"issue":"2","key":"10528_CR30","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1161\/circheartfailure.114.001825","volume":"8","author":"BP Dhakal","year":"2015","unstructured":"Dhakal BP, Malhotra R, Murphy RM et al (2015) Mechanisms of exercise intolerance in heart failure with preserved ejection fraction: the role of abnormal peripheral oxygen extraction. Circ Heart Fail 8(2):286\u2013294. https:\/\/doi.org\/10.1161\/circheartfailure.114.001825","journal-title":"Circ Heart Fail"},{"key":"10528_CR31","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.ijcard.2018.04.102","volume":"267","author":"UL Fax\u00e9n","year":"2018","unstructured":"Fax\u00e9n UL, Hage C, Donal E, Daubert JC, Linde C, Lund LH (2018) Patient reported outcome in HFpEF: sex-specific differences in quality of life and association with outcome. Int J Cardiol 267:128\u2013132. https:\/\/doi.org\/10.1016\/j.ijcard.2018.04.102","journal-title":"Int J Cardiol"},{"issue":"3","key":"10528_CR32","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1016\/j.cardfail.2020.01.001","volume":"26","author":"MC Honigberg","year":"2020","unstructured":"Honigberg MC, Lau ES, Jones AD et al (2020) Sex differences in exercise capacity and quality of life in heart failure with preserved ejection fraction: a secondary analysis of the RELAX and NEAT-HFpEF trials. J Cardiac Fail 26(3):276\u2013280. https:\/\/doi.org\/10.1016\/j.cardfail.2020.01.001","journal-title":"J Cardiac Fail"},{"issue":"6","key":"10528_CR33","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1161\/circheartfailure.112.968594","volume":"5","author":"SF Mohammed","year":"2012","unstructured":"Mohammed SF, Borlaug BA, Roger VL et al (2012) Comorbidity and ventricular and vascular structure and function in heart failure with preserved ejection fraction: a community-based study. Circ Heart Fail 5(6):710\u2013719. https:\/\/doi.org\/10.1161\/circheartfailure.112.968594","journal-title":"Circ Heart Fail"},{"issue":"3","key":"10528_CR34","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.jchf.2019.01.003","volume":"7","author":"M Merrill","year":"2019","unstructured":"Merrill M, Sweitzer NK, Lindenfeld J, Kao DP (2019) Sex differences in outcomes and responses to spironolactone in heart failure with preserved ejection fraction: a secondary analysis of TOPCAT Trial. JACC Heart Fail 7(3):228\u2013238. https:\/\/doi.org\/10.1016\/j.jchf.2019.01.003","journal-title":"JACC Heart Fail"},{"issue":"4","key":"10528_CR35","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/j.amjms.2018.06.009","volume":"356","author":"E Harada","year":"2018","unstructured":"Harada E, Mizuno Y, Kugimiya F et al (2018) Sex differences in heart failure with preserved ejection fraction reflected by B-type natriuretic peptide level. Am J Med Sci 356(4):335\u2013343. https:\/\/doi.org\/10.1016\/j.amjms.2018.06.009","journal-title":"Am J Med Sci"},{"issue":"5","key":"10528_CR36","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1002\/ejhf.1771","volume":"22","author":"N Suthahar","year":"2020","unstructured":"Suthahar N, Meems LMG, Ho JE, de Boer RA (2020) Sex-related differences in contemporary biomarkers for heart failure: a review. Eur J Heart Fail 22(5):775\u2013788. https:\/\/doi.org\/10.1002\/ejhf.1771","journal-title":"Eur J Heart Fail"},{"issue":"8","key":"10528_CR37","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1002\/ejhf.1209","volume":"20","author":"N Suthahar","year":"2018","unstructured":"Suthahar N, Meijers WC, Ho JE et al (2018) Sex-specific associations of obesity and N-terminal pro-B-type natriuretic peptide levels in the general population. Eur J Heart Fail 20(8):1205\u20131214. https:\/\/doi.org\/10.1002\/ejhf.1209","journal-title":"Eur J Heart Fail"},{"issue":"6","key":"10528_CR38","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1007\/s11897-022-00578-7","volume":"19","author":"M Eltelbany","year":"2022","unstructured":"Eltelbany M, Shah P, deFilippi C (2022) Biomarkers in HFpEF for diagnosis, prognosis, and biological phenotyping. Curr Heart Fail Rep 19(6):412\u2013424. https:\/\/doi.org\/10.1007\/s11897-022-00578-7","journal-title":"Curr Heart Fail Rep"},{"issue":"1 Pt C","key":"10528_CR39","doi-asserted-by":"publisher","DOI":"10.1016\/j.cpcardiol.2023.102155","volume":"49","author":"SP Shaik","year":"2024","unstructured":"Shaik SP, Karan HH, Singh A et al (2024) HFpEF: new biomarkers and their diagnostic and prognostic value. Curr Probl Cardiol 49(1 Pt C):102155. https:\/\/doi.org\/10.1016\/j.cpcardiol.2023.102155","journal-title":"Curr Probl Cardiol"},{"issue":"1","key":"10528_CR40","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1007\/s11897-023-00634-w","volume":"21","author":"RA Rao","year":"2024","unstructured":"Rao RA, Bhardwaj A, Munagala M et al (2024) Sex differences in circulating biomarkers of heart failure. Curr Heart Fail Rep 21(1):11\u201321. https:\/\/doi.org\/10.1007\/s11897-023-00634-w","journal-title":"Curr Heart Fail Rep"},{"issue":"3","key":"10528_CR41","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/j.hfc.2021.02.001","volume":"17","author":"JC Youn","year":"2021","unstructured":"Youn JC, Ahn Y, Jung HO (2021) Pathophysiology of heart failure with preserved ejection fraction. Heart Fail Clin 17(3):327\u2013335. https:\/\/doi.org\/10.1016\/j.hfc.2021.02.001","journal-title":"Heart Fail Clin"},{"issue":"47","key":"10528_CR42","doi-asserted-by":"publisher","first-page":"3859","DOI":"10.1093\/eurheartj\/ehz835","volume":"40","author":"CSP Lam","year":"2019","unstructured":"Lam CSP, Arnott C, Beale AL et al (2019) Sex differences in heart failure. Eur Heart J 40(47):3859\u20133868c. https:\/\/doi.org\/10.1093\/eurheartj\/ehz835","journal-title":"Eur Heart J"},{"issue":"8","key":"10528_CR43","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1002\/ejhf.2563","volume":"24","author":"H Sorimachi","year":"2022","unstructured":"Sorimachi H, Omote K, Omar M et al (2022) Sex and central obesity in heart failure with preserved ejection fraction. Eur J Heart Fail 24(8):1359\u20131370. https:\/\/doi.org\/10.1002\/ejhf.2563","journal-title":"Eur J Heart Fail"},{"issue":"5","key":"10528_CR44","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1002\/ejhf.67","volume":"16","author":"M Gori","year":"2014","unstructured":"Gori M, Lam CS, Gupta DK et al (2014) Sex-specific cardiovascular structure and function in heart failure with preserved ejection fraction. Eur J Heart Fail 16(5):535\u2013542. https:\/\/doi.org\/10.1002\/ejhf.67","journal-title":"Eur J Heart Fail"},{"key":"10528_CR45","doi-asserted-by":"publisher","first-page":"174550572211402","DOI":"10.1177\/17455057221140209","volume":"18","author":"G Kaur","year":"2022","unstructured":"Kaur G, Lau E (2022) Sex differences in heart failure with preserved ejection fraction: from traditional risk factors to sex-specific risk factors. Womens Health (Lond) 18:17455057221140209. https:\/\/doi.org\/10.1177\/17455057221140209","journal-title":"Womens Health (Lond)"},{"key":"10528_CR46","doi-asserted-by":"publisher","unstructured":"Hoshida S, Watanabe T, Shinoda Y et al (2008) Sex-related differences in left ventricular diastolic function and arterial elastance during admission in patients with heart failure with preserved ejection fraction: The PURSUIT HFpEF study. Clin Cardiol 41(12):1529-1536. https:\/\/doi.org\/10.1002\/clc.23073","DOI":"10.1002\/clc.23073"},{"issue":"3","key":"10528_CR47","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1016\/j.hfc.2021.02.009","volume":"17","author":"H Sorimachi","year":"2021","unstructured":"Sorimachi H, Omote K, Borlaug BA (2021) Clinical phenogroups in heart failure with preserved ejection fraction. Heart Fail Clin 17(3):483\u2013498. https:\/\/doi.org\/10.1016\/j.hfc.2021.02.009","journal-title":"Heart Fail Clin"},{"issue":"6","key":"10528_CR48","doi-asserted-by":"publisher","first-page":"2402","DOI":"10.1016\/j.chest.2020.12.028","volume":"159","author":"I Singh","year":"2021","unstructured":"Singh I, Oliveira RKF, Heerdt PM, Pari R, Systrom DM, Waxman AB (2021) Sex-related differences in dynamic right ventricular-pulmonary vascular coupling in heart failure with preserved ejection fraction. Chest 159(6):2402\u20132416. https:\/\/doi.org\/10.1016\/j.chest.2020.12.028","journal-title":"Chest"},{"issue":"1","key":"10528_CR49","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.ccm.2020.11.002","volume":"42","author":"YNV Reddy","year":"2021","unstructured":"Reddy YNV, Borlaug BA (2021) Pulmonary hypertension in left heart disease. Clin Chest Med 42(1):39\u201358. https:\/\/doi.org\/10.1016\/j.ccm.2020.11.002","journal-title":"Clin Chest Med"},{"issue":"13","key":"10528_CR50","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1016\/j.jacc.2008.11.051","volume":"53","author":"CS Lam","year":"2009","unstructured":"Lam CS, Roger VL, Rodeheffer RJ, Borlaug BA, Enders FT, Redfield MM (2009) Pulmonary hypertension in heart failure with preserved ejection fraction: a community-based study. J Am Coll Cardiol 53(13):1119\u20131126. https:\/\/doi.org\/10.1016\/j.jacc.2008.11.051","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"10528_CR51","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1001\/jamacardio.2019.4150","volume":"5","author":"ES Lau","year":"2020","unstructured":"Lau ES, Cunningham T, Hardin KM et al (2020) Sex differences in cardiometabolic traits and determinants of exercise capacity in heart failure with preserved ejection fraction. JAMA Cardiol 5(1):30\u201337. https:\/\/doi.org\/10.1001\/jamacardio.2019.4150","journal-title":"JAMA Cardiol"},{"issue":"3","key":"10528_CR52","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/j.jchf.2019.01.004","volume":"7","author":"AL Beale","year":"2019","unstructured":"Beale AL, Nanayakkara S, Segan L et al (2019) Sex differences in heart failure with preserved ejection fraction pathophysiology: a detailed invasive hemodynamic and echocardiographic analysis. JACC Heart Fail 7(3):239\u2013249. https:\/\/doi.org\/10.1016\/j.jchf.2019.01.004","journal-title":"JACC Heart Fail"},{"issue":"16","key":"10528_CR53","doi-asserted-by":"publisher","first-page":"1595","DOI":"10.1093\/eurheartj\/ehaa823","volume":"42","author":"H Sorimachi","year":"2021","unstructured":"Sorimachi H, Obokata M, Takahashi N et al (2021) Pathophysiologic importance of visceral adipose tissue in women with heart failure and preserved ejection fraction. Eur Heart J 42(16):1595\u20131605. https:\/\/doi.org\/10.1093\/eurheartj\/ehaa823","journal-title":"Eur Heart J"},{"issue":"1","key":"10528_CR54","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1002\/ehf2.12557","volume":"7","author":"AL Beale","year":"2020","unstructured":"Beale AL, Cosentino C, Segan L et al (2020) The effect of parity on exercise physiology in women with heart failure with preserved ejection fraction. ESC Heart Fail 7(1):213\u2013222. https:\/\/doi.org\/10.1002\/ehf2.12557","journal-title":"ESC Heart Fail"},{"issue":"7-8","key":"10528_CR55","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1007\/s12471-020-01534-7","volume":"29","author":"A Uijl","year":"2021","unstructured":"Uijl A, Veenis JF, Brunner-La Rocca HP et al (2021) Clinical profile and contemporary management of patients with heart failure with preserved ejection fraction: results from the CHECK-HF registry. Neth Heart J 29(7-8):370\u2013376. https:\/\/doi.org\/10.1007\/s12471-020-01534-7","journal-title":"Neth Heart J"},{"issue":"12","key":"10528_CR56","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1016\/j.jchf.2018.07.009","volume":"6","author":"VN Rao","year":"2018","unstructured":"Rao VN, Zhao D, Allison MA et al (2018) Adiposity and incident heart failure and its subtypes: MESA (multi-ethnic study of atherosclerosis). JACC Heart Fail 6(12):999\u20131007. https:\/\/doi.org\/10.1016\/j.jchf.2018.07.009","journal-title":"JACC Heart Fail"},{"issue":"8","key":"10528_CR57","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1016\/j.jchf.2018.05.018","volume":"6","author":"N Savji","year":"2018","unstructured":"Savji N, Meijers WC, Bartz TM et al (2018) The association of obesity and cardiometabolic traits with incident HFpEF and HFrEF. JACC Heart Fail 6(8):701\u2013709. https:\/\/doi.org\/10.1016\/j.jchf.2018.05.018","journal-title":"JACC Heart Fail"},{"issue":"9","key":"10528_CR58","doi-asserted-by":"publisher","first-page":"1540","DOI":"10.1002\/ejhf.1956","volume":"22","author":"VN Rao","year":"2020","unstructured":"Rao VN, Fudim M, Mentz RJ, Michos ED, Felker GM (2020) Regional adiposity and heart failure with preserved ejection fraction. Eur J Heart Fail 22(9):1540\u20131550. https:\/\/doi.org\/10.1002\/ejhf.1956","journal-title":"Eur J Heart Fail"},{"issue":"1","key":"10528_CR59","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1007\/s10741-023-10369-4","volume":"29","author":"M Abubakar","year":"2024","unstructured":"Abubakar M, Saleem A, Hajjaj M et al (2024) Sex-specific differences in risk factors, comorbidities, diagnostic challenges, optimal management, and prognostic outcomes of heart failure with preserved ejection fraction: a comprehensive literature review. Heart Fail Rev 29(1):235\u2013256. https:\/\/doi.org\/10.1007\/s10741-023-10369-4","journal-title":"Heart Fail Rev"},{"issue":"1","key":"10528_CR60","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.jaccas.2019.11.065","volume":"2","author":"A Sinha","year":"2020","unstructured":"Sinha A, Yancy CW, Shah SJ, Khan SS (2020) Heart failure with preserved ejection fraction and obesity: syndrome of cGMP-PKG deficiency in post-menopausal women. JACC Case Rep 2(1):28\u201332. https:\/\/doi.org\/10.1016\/j.jaccas.2019.11.065","journal-title":"JACC Case Rep"},{"issue":"1","key":"10528_CR61","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/s13293-020-00306-7","volume":"11","author":"AR Sabbatini","year":"2020","unstructured":"Sabbatini AR, Kararigas G (2020) Estrogen-related mechanisms in sex differences of hypertension and target organ damage. Biol Sex Differ 11(1):31. https:\/\/doi.org\/10.1186\/s13293-020-00306-7","journal-title":"Biol Sex Differ"},{"key":"10528_CR62","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.maturitas.2017.07.010","volume":"104","author":"E Armeni","year":"2017","unstructured":"Armeni E, Lambrinoudaki I (2017) Androgens and cardiovascular disease in women and men. Maturitas 104:54\u201372. https:\/\/doi.org\/10.1016\/j.maturitas.2017.07.010","journal-title":"Maturitas"},{"issue":"7","key":"10528_CR63","doi-asserted-by":"publisher","DOI":"10.1161\/circheartfailure.121.008755","volume":"15","author":"E Di Lodovico","year":"2022","unstructured":"Di Lodovico E, Facondo P, Delbarba A et al (2022) Testosterone, hypogonadism, and heart failure. Circ Heart Failure 15(7):e008755. https:\/\/doi.org\/10.1161\/circheartfailure.121.008755","journal-title":"Circ Heart Failure"},{"key":"10528_CR64","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.maturitas.2017.11.006","volume":"108","author":"V Subramanya","year":"2018","unstructured":"Subramanya V, Zhao D, Ouyang P et al (2018) Sex hormone levels and change in left ventricular structure among men and post-menopausal women: the multi-ethnic study of atherosclerosis (MESA). Maturitas 108:37\u201344. https:\/\/doi.org\/10.1016\/j.maturitas.2017.11.006","journal-title":"Maturitas"},{"issue":"7","key":"10528_CR65","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1089\/jwh.2018.7441","volume":"28","author":"L Mathews","year":"2019","unstructured":"Mathews L, Subramanya V, Zhao D et al (2019) Endogenous sex hormones and endothelial function in postmenopausal women and men: the multi-ethnic study of atherosclerosis. J Women's Health 28(7):900\u2013909. https:\/\/doi.org\/10.1089\/jwh.2018.7441","journal-title":"J Women's Health"},{"issue":"7","key":"10528_CR66","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1093\/ajh\/hpy024","volume":"31","author":"V Subramanya","year":"2018","unstructured":"Subramanya V, Ambale-Venkatesh B, Ohyama Y et al (2018) Relation of sex hormone levels with prevalent and 10-year change in aortic distensibility assessed by mri: the multi-ethnic study of atherosclerosis. Am J Hypertens 31(7):774\u2013783. https:\/\/doi.org\/10.1093\/ajh\/hpy024","journal-title":"Am J Hypertens"},{"key":"10528_CR67","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1111\/eci.12447","volume":"45","author":"S Salerni","year":"2015","unstructured":"Salerni S, Francescomarino SD, Cadeddu C, Acquistapace F, Maffei S, Gallina S (2015) The different role of sex hormones on female cardiovascular physiology and functions: not only estrogens. Eur J Clin Invest 45:634\u2013645","journal-title":"Eur J Clin Invest"},{"issue":"6","key":"10528_CR68","doi-asserted-by":"publisher","first-page":"625","DOI":"10.3109\/13697137.2014.887669","volume":"17","author":"I Spoletini","year":"2014","unstructured":"Spoletini I, Vitale C, Pelliccia F, Fossati C, Rosano GM (2014) Androgens and cardiovascular disease in postmenopausal women: a systematic review. Climacteric : the journal of the International Menopause Society 17(6):625\u2013634. https:\/\/doi.org\/10.3109\/13697137.2014.887669","journal-title":"Climacteric : the journal of the International Menopause Society"},{"key":"10528_CR69","doi-asserted-by":"publisher","unstructured":"Ying W, Post WS, Michos ED et al (2021) Associations between menopause, cardiac remodeling, and diastolic function: the CARDIA study. Menopause. https:\/\/doi.org\/10.1097\/gme.0000000000001815","DOI":"10.1097\/gme.0000000000001815"},{"issue":"10","key":"10528_CR70","doi-asserted-by":"publisher","first-page":"e3798","DOI":"10.1210\/clinem\/dgaa500","volume":"105","author":"D Zhao","year":"2020","unstructured":"Zhao D, Guallar E, Ballantyne CM et al (2020) Sex hormones and incident heart failure in men and postmenopausal women: the atherosclerosis risk in communities study. J Clin Endocrinol Metab 105(10):e3798\u2013e3807. https:\/\/doi.org\/10.1210\/clinem\/dgaa500","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"10528_CR71","doi-asserted-by":"publisher","first-page":"205","DOI":"10.3109\/13697137.2012.733983","volume":"16","author":"F Labrie","year":"2013","unstructured":"Labrie F, Labrie C (2013) DHEA and intracrinology at menopause, a positive choice for evolution of the human species. Climacteric : the journal of the International Menopause Society 16(2):205\u2013213. https:\/\/doi.org\/10.3109\/13697137.2012.733983","journal-title":"Climacteric : the journal of the International Menopause Society"},{"issue":"21","key":"10528_CR72","doi-asserted-by":"publisher","DOI":"10.1161\/jaha.122.026953","volume":"11","author":"JN Njoroge","year":"2022","unstructured":"Njoroge JN, Tressel W, Biggs ML et al (2022) Circulating androgen concentrations and risk of incident heart failure in older men: the cardiovascular health study. J Am Heart Assoc 11(21):e026953. https:\/\/doi.org\/10.1161\/jaha.122.026953","journal-title":"J Am Heart Assoc"},{"issue":"7","key":"10528_CR73","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1016\/j.cjca.2014.03.020","volume":"30","author":"T Coutinho","year":"2014","unstructured":"Coutinho T (2014) Arterial stiffness and its clinical implications in women. Can J Cardiol 30(7):756\u2013764. https:\/\/doi.org\/10.1016\/j.cjca.2014.03.020","journal-title":"Can J Cardiol"},{"issue":"4","key":"10528_CR74","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1007\/s10741-022-10274-2","volume":"28","author":"D Shuaishuai","year":"2023","unstructured":"Shuaishuai D, Jingyi L, Zhiqiang Z, Guanwei F (2023) Sex differences and related estrogenic effects in heart failure with preserved ejection fraction. Heart Fail Rev 28(4):937\u2013948. https:\/\/doi.org\/10.1007\/s10741-022-10274-2","journal-title":"Heart Fail Rev"},{"issue":"8","key":"10528_CR75","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1093\/ehjci\/jeaa079","volume":"22","author":"MZ Wu","year":"2021","unstructured":"Wu MZ, Chen Y, Yu YJ et al (2021) Sex-specific pattern of left ventricular hypertrophy and diastolic function in patients with type 2 diabetes mellitus. Eur Heart J Cardiovasc Imaging 22(8):930\u2013940. https:\/\/doi.org\/10.1093\/ehjci\/jeaa079","journal-title":"Eur Heart J Cardiovasc Imaging"},{"issue":"6","key":"10528_CR76","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.1097\/hjh.0000000000003127","volume":"40","author":"A Cai","year":"2022","unstructured":"Cai A, Liu L, Zhou D, Tang S, Zhou Y, Feng Y (2022) Influences of achieved SBP on age and sex-related left ventricular structural alteration in community hypertensive populations. J Hypertens 40(6):1170\u20131178. https:\/\/doi.org\/10.1097\/hjh.0000000000003127","journal-title":"J Hypertens"},{"issue":"7","key":"10528_CR77","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.1111\/jch.14262","volume":"23","author":"A Cai","year":"2021","unstructured":"Cai A, Zhou D, Liu L, Zhou Y, Tang S, Feng Y (2021) Age-related alterations in cardiac and arterial structure and function in hypertensive women and men. J Clin Hypertens (Greenwich, Conn) 23(7):1322\u20131334. https:\/\/doi.org\/10.1111\/jch.14262","journal-title":"J Clin Hypertens (Greenwich, Conn)"},{"issue":"15","key":"10528_CR78","doi-asserted-by":"publisher","first-page":"2254","DOI":"10.1161\/circulationaha.105.541078","volume":"112","author":"MM Redfield","year":"2005","unstructured":"Redfield MM, Jacobsen SJ, Borlaug BA, Rodeheffer RJ, Kass DA (2005) Age- and gender-related ventricular-vascular stiffening: a community-based study. Circulation 112(15):2254\u20132262. https:\/\/doi.org\/10.1161\/circulationaha.105.541078","journal-title":"Circulation"},{"issue":"6","key":"10528_CR79","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1016\/j.ahj.2015.08.019","volume":"170","author":"WW Nichols","year":"2015","unstructured":"Nichols WW, Denardo SJ, Davidson JB, Huo T, Bairey Merz CN, Pepine CJ (2015) Association of aortic stiffness and wave reflections with coronary flow reserve in women without obstructive coronary artery disease: An ancillary study from the National Heart, Lung, and Blood Institute-sponsored Women's Ischemia Syndrome Evaluation (WISE). Am Heart J 170(6):1243\u20131254. https:\/\/doi.org\/10.1016\/j.ahj.2015.08.019","journal-title":"Am Heart J"},{"key":"10528_CR80","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.amjcard.2023.07.031","volume":"205","author":"R Crosier","year":"2023","unstructured":"Crosier R, Paquin A, Zhu T et al (2023) Sex differences in systemic and coronary arterial hemodynamics in heart failure with preserved ejection fraction. Am J Cardiol 205:87\u201393. https:\/\/doi.org\/10.1016\/j.amjcard.2023.07.031","journal-title":"Am J Cardiol"},{"issue":"6","key":"10528_CR81","doi-asserted-by":"publisher","first-page":"3729","DOI":"10.1002\/ehf2.14569","volume":"10","author":"M Erhardsson","year":"2023","unstructured":"Erhardsson M, Ljung Fax\u00e9n U, Venkateshvaran A et al (2023) Regional differences and coronary microvascular dysfunction in heart failure with preserved ejection fraction. ESC Heart Fail 10(6):3729\u20133734. https:\/\/doi.org\/10.1002\/ehf2.14569","journal-title":"ESC Heart Fail"},{"issue":"4","key":"10528_CR82","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1002\/ejhf.2435","volume":"24","author":"C Chandramouli","year":"2022","unstructured":"Chandramouli C, Ting TW, Tromp J et al (2022) Sex differences in proteomic correlates of coronary microvascular dysfunction among patients with heart failure and preserved ejection fraction. Eur J Heart Fail 24(4):681\u2013684. https:\/\/doi.org\/10.1002\/ejhf.2435","journal-title":"Eur J Heart Fail"},{"issue":"2","key":"10528_CR83","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1007\/s11883-018-0710-5","volume":"20","author":"S Naderi","year":"2018","unstructured":"Naderi S (2018) Microvascular coronary dysfunction-an overview. Curr Atheroscler Rep 20(2):7. https:\/\/doi.org\/10.1007\/s11883-018-0710-5","journal-title":"Curr Atheroscler Rep"},{"issue":"4","key":"10528_CR84","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1016\/j.jcmg.2016.02.003","volume":"9","author":"MB Patel","year":"2016","unstructured":"Patel MB, Bui LP, Kirkeeide RL, Gould KL (2016) Imaging microvascular dysfunction and mechanisms for female-male differences in CAD. JACC Cardiovasc Imaging 9(4):465\u2013482. https:\/\/doi.org\/10.1016\/j.jcmg.2016.02.003","journal-title":"JACC Cardiovasc Imaging"},{"key":"10528_CR85","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.ijcard.2018.06.072","volume":"270","author":"T Coutinho","year":"2018","unstructured":"Coutinho T, Mielniczuk LM, Srivaratharajah K, deKemp R, Wells GA, Beanlands RS (2018) Coronary artery microvascular dysfunction: Role of sex and arterial load. Int J Cardiol 270:42\u201347. https:\/\/doi.org\/10.1016\/j.ijcard.2018.06.072","journal-title":"Int J Cardiol"},{"key":"10528_CR86","doi-asserted-by":"publisher","first-page":"442","DOI":"10.3389\/fendo.2019.00442","volume":"10","author":"AA Sickinghe","year":"2019","unstructured":"Sickinghe AA, Korporaal SJA, den Ruijter HM, Kessler EL (2019) Estrogen contributions to microvascular dysfunction evolving to heart failure with preserved ejection fraction. Front Endocrinol 10:442. https:\/\/doi.org\/10.3389\/fendo.2019.00442","journal-title":"Front Endocrinol"},{"issue":"9","key":"10528_CR87","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1161\/circulationaha.118.034646","volume":"138","author":"YNV Reddy","year":"2018","unstructured":"Reddy YNV, Carter RE, Obokata M, Redfield MM, Borlaug BA (2018) A simple, evidence-based approach to help guide diagnosis of heart failure with preserved ejection fraction. Circulation 138(9):861\u2013870. https:\/\/doi.org\/10.1161\/circulationaha.118.034646","journal-title":"Circulation"},{"issue":"40","key":"10528_CR88","doi-asserted-by":"publisher","first-page":"3297","DOI":"10.1093\/eurheartj\/ehz641","volume":"40","author":"B Pieske","year":"2019","unstructured":"Pieske B, Tsch\u00f6pe C, de Boer RA et al (2019) How to diagnose heart failure with preserved ejection fraction: the HFA-PEFF diagnostic algorithm: a consensus recommendation from the Heart Failure Association (HFA) of the European Society of Cardiology (ESC). Eur Heart J 40(40):3297\u20133317. https:\/\/doi.org\/10.1093\/eurheartj\/ehz641","journal-title":"Eur Heart J"},{"issue":"3","key":"10528_CR89","doi-asserted-by":"publisher","first-page":"2089","DOI":"10.1002\/ehf2.13288","volume":"8","author":"V Parcha","year":"2021","unstructured":"Parcha V, Malla G, Kalra R et al (2021) Diagnostic and prognostic implications of heart failure with preserved ejection fraction scoring systems. ESC heart Fail 8(3):2089\u20132102. https:\/\/doi.org\/10.1002\/ehf2.13288","journal-title":"ESC heart Fail"},{"issue":"3","key":"10528_CR90","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.jchf.2019.09.009","volume":"8","author":"JB Cohen","year":"2020","unstructured":"Cohen JB, Schrauben SJ, Zhao L et al (2020) Clinical phenogroups in heart failure with preserved ejection fraction: detailed phenotypes, prognosis, and response to spironolactone. JACC Heart Fail 8(3):172\u2013184. https:\/\/doi.org\/10.1016\/j.jchf.2019.09.009","journal-title":"JACC Heart Fail"},{"issue":"8","key":"10528_CR91","doi-asserted-by":"publisher","first-page":"e347","DOI":"10.1161\/cir.0000000000001209","volume":"149","author":"SS Martin","year":"2024","unstructured":"Martin SS, Aday AW, Almarzooq ZI et al (2024) Heart disease and stroke statistics: a report of US and global data from the American Heart Association. Circulation 149(8):e347\u2013e913. https:\/\/doi.org\/10.1161\/cir.0000000000001209","journal-title":"Circulation"},{"issue":"1","key":"10528_CR92","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1007\/s10741-024-10442-6","volume":"30","author":"LA Ammar","year":"2025","unstructured":"Ammar LA, Massoud GP, Chidiac C, Booz GW, Altara R, Zouein FA (2025) BNP and NT-proBNP as prognostic biomarkers for the prediction of adverse outcomes in HFpEF patients: a systematic review and meta-analysis. Heart Fail Rev 30(1):45\u201354. https:\/\/doi.org\/10.1007\/s10741-024-10442-6","journal-title":"Heart Fail Rev"},{"issue":"2","key":"10528_CR93","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1161\/circheartfailure.113.000854","volume":"7","author":"MA Burke","year":"2014","unstructured":"Burke MA, Katz DH, Beussink L et al (2014) Prognostic importance of pathophysiologic markers in patients with heart failure and preserved ejection fraction. Circ Heart Fail 7(2):288\u2013299. https:\/\/doi.org\/10.1161\/circheartfailure.113.000854","journal-title":"Circ Heart Fail"},{"issue":"16","key":"10528_CR94","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1056\/NEJMoa2107038","volume":"385","author":"SD Anker","year":"2021","unstructured":"Anker SD, Butler J, Filippatos G et al (2021) Empagliflozin in heart failure with a preserved ejection fraction. New Engl J Med 385(16):1451\u20131461. https:\/\/doi.org\/10.1056\/NEJMoa2107038","journal-title":"New Engl J Med"},{"key":"10528_CR95","doi-asserted-by":"publisher","unstructured":"Solomon SD, McMurray JJV, Claggett B et al (2022) Dapagliflozin in heart failure with mildly reduced or preserved ejection fraction. New Engl J Med 387(12):1089\u20131098. https:\/\/doi.org\/10.1056\/NEJMoa2206286","DOI":"10.1056\/NEJMoa2206286"},{"issue":"16","key":"10528_CR96","doi-asserted-by":"publisher","first-page":"1475","DOI":"10.1056\/NEJMoa2407107","volume":"391","author":"SD Solomon","year":"2024","unstructured":"Solomon SD, McMurray JJV, Vaduganathan M et al (2024) Finerenone in Heart Failure with Mildly Reduced or Preserved Ejection Fraction. New Engl J Med 391(16):1475\u20131485. https:\/\/doi.org\/10.1056\/NEJMoa2407107","journal-title":"New Engl J Med"},{"issue":"5","key":"10528_CR97","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1161\/circulationaha.119.044491","volume":"141","author":"JJV McMurray","year":"2020","unstructured":"McMurray JJV, Jackson AM, Lam CSP et al (2020) Effects of sacubitril-valsartan versus valsartan in women compared with men with heart failure and preserved ejection fraction: insights from PARAGON-HF. Circulation 141(5):338\u2013351. https:\/\/doi.org\/10.1161\/circulationaha.119.044491","journal-title":"Circulation"},{"issue":"9386","key":"10528_CR98","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1016\/s0140-6736(03)14285-7","volume":"362","author":"S Yusuf","year":"2003","unstructured":"Yusuf S, Pfeffer MA, Swedberg K et al (2003) Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved Trial. Lancet 362(9386):777\u2013781. https:\/\/doi.org\/10.1016\/s0140-6736(03)14285-7","journal-title":"Lancet"},{"issue":"15","key":"10528_CR99","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1056\/NEJMoa1313731","volume":"370","author":"B Pitt","year":"2014","unstructured":"Pitt B, Pfeffer MA, Assmann SF et al (2014) Spironolactone for heart failure with preserved ejection fraction. New Engl J Med 370(15):1383\u20131392. https:\/\/doi.org\/10.1056\/NEJMoa1313731","journal-title":"New Engl J Med"},{"key":"10528_CR100","doi-asserted-by":"publisher","unstructured":"Packer M, Zile MR, Kramer CM et al (2024) Tirzepatide for heart failure with preserved ejection fraction and obesity. New Engl J Med. https:\/\/doi.org\/10.1056\/NEJMoa2410027","DOI":"10.1056\/NEJMoa2410027"},{"issue":"3","key":"10528_CR101","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.jacc.2024.04.038","volume":"84","author":"M Schou","year":"2024","unstructured":"Schou M, Petrie MC, Borlaug BA et al (2024) Semaglutide and NYHA functional class in obesity-related heart failure with preserved ejection fraction: The STEP-HFpEF program. J Am Coll Cardiol 84(3):247\u2013257. https:\/\/doi.org\/10.1016\/j.jacc.2024.04.038","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"10528_CR102","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1001\/jama.2015.17346","volume":"315","author":"DW Kitzman","year":"2016","unstructured":"Kitzman DW, Brubaker P, Morgan T et al (2016) Effect of caloric restriction or aerobic exercise training on peak oxygen consumption and quality of life in obese older patients with heart failure with preserved ejection fraction: a randomized clinical trial. JAMA 315(1):36\u201346. https:\/\/doi.org\/10.1001\/jama.2015.17346","journal-title":"JAMA"},{"issue":"1","key":"10528_CR103","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1001\/jamacardio.2024.4613","volume":"10","author":"M Chimura","year":"2025","unstructured":"Chimura M, Wang X, Jhund PS et al (2025) Finerenone in women and men with heart failure with mildly reduced or preserved ejection fraction: a secondary analysis of the FINEARTS-HF randomized clinical trial. JAMA Cardiol 10(1):59\u201370. https:\/\/doi.org\/10.1001\/jamacardio.2024.4613","journal-title":"JAMA Cardiol"},{"issue":"8","key":"10528_CR104","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1161\/circulationaha.122.062832","volume":"147","author":"X Wang","year":"2023","unstructured":"Wang X, Vaduganathan M, Claggett BL et al (2023) Sex differences in characteristics, outcomes, and treatment response with dapagliflozin across the range of ejection fraction in patients with heart failure: insights from DAPA-HF and deliver. Circulation 147(8):624\u2013634. https:\/\/doi.org\/10.1161\/circulationaha.122.062832","journal-title":"Circulation"},{"issue":"14","key":"10528_CR105","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1161\/circulationaha.122.059755","volume":"146","author":"J Butler","year":"2022","unstructured":"Butler J, Filippatos G, Siddiqi TJ et al (2022) Effects of empagliflozin in women and men with heart failure and preserved ejection fraction. Circulation 146(14):1046\u20131055. https:\/\/doi.org\/10.1161\/circulationaha.122.059755","journal-title":"Circulation"},{"issue":"23","key":"10528_CR106","doi-asserted-by":"publisher","first-page":"2456","DOI":"10.1056\/NEJMoa0805450","volume":"359","author":"BM Massie","year":"2008","unstructured":"Massie BM, Carson PE, McMurray JJ et al (2008) Irbesartan in patients with heart failure and preserved ejection fraction. New Engl J Med 359(23):2456\u20132467. https:\/\/doi.org\/10.1056\/NEJMoa0805450","journal-title":"New Engl J Med"},{"issue":"5","key":"10528_CR107","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1161\/circulationaha.106.628347","volume":"114","author":"A Ahmed","year":"2006","unstructured":"Ahmed A, Rich MW, Fleg JL et al (2006) Effects of digoxin on morbidity and mortality in diastolic heart failure: the ancillary digitalis investigation group trial. Circulation 114(5):397\u2013403. https:\/\/doi.org\/10.1161\/circulationaha.106.628347","journal-title":"Circulation"},{"key":"10528_CR108","doi-asserted-by":"publisher","unstructured":"Sachdev V, Sharma K, Keteyian SJ et al (2023) supervised exercise training for chronic heart failure with preserved ejection fraction: a scientific statement from the american heart association and american college of cardiology. Circulation 147(16):e699\u2013e715. https:\/\/doi.org\/10.1161\/cir.0000000000001122","DOI":"10.1161\/cir.0000000000001122"},{"issue":"1","key":"10528_CR109","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1161\/circheartfailure.114.001615","volume":"8","author":"A Pandey","year":"2015","unstructured":"Pandey A, Parashar A, Kumbhani D et al (2015) Exercise training in patients with heart failure and preserved ejection fraction: meta-analysis of randomized control trials. Circulation Heart Fail 8(1):33\u201340. https:\/\/doi.org\/10.1161\/circheartfailure.114.001615","journal-title":"Circulation Heart Fail"},{"issue":"19","key":"10528_CR110","doi-asserted-by":"publisher","first-page":"4901","DOI":"10.1113\/jp277764","volume":"597","author":"DR Seals","year":"2019","unstructured":"Seals DR, Nagy EE, Moreau KL (2019) Aerobic exercise training and vascular function with ageing in healthy men and women. J Physiol 597(19):4901\u20134914. https:\/\/doi.org\/10.1113\/jp277764","journal-title":"J Physiol"},{"issue":"1","key":"10528_CR111","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1186\/s12916-022-02650-4","volume":"20","author":"A van Ommen","year":"2022","unstructured":"van Ommen A, Canto ED, Cramer MJ, Rutten FH, Onland-Moret NC, Ruijter HMD (2022) Diastolic dysfunction and sex-specific progression to HFpEF: current gaps in knowledge and future directions. BMC Med 20(1):496. https:\/\/doi.org\/10.1186\/s12916-022-02650-4","journal-title":"BMC Med"},{"issue":"9","key":"10528_CR112","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.1016\/j.cardfail.2022.04.013","volume":"28","author":"L Balkan","year":"2022","unstructured":"Balkan L, Ringel JB, Levitan EB et al (2022) Association of perceived stress with incident heart failure. J Cardiac Fail 28(9):1401\u20131410. https:\/\/doi.org\/10.1016\/j.cardfail.2022.04.013","journal-title":"J Cardiac Fail"},{"issue":"3","key":"10528_CR113","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1007\/s10741-020-10056-8","volume":"26","author":"KM Harris","year":"2021","unstructured":"Harris KM, Jacoby DL, Lampert R, Soucier RJ, Burg MM (2021) Psychological stress in heart failure: a potentially actionable disease modifier. Heart Fail Rev 26(3):561\u2013575. https:\/\/doi.org\/10.1007\/s10741-020-10056-8","journal-title":"Heart Fail Rev"},{"issue":"3","key":"10528_CR114","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1016\/j.jacc.2024.05.016","volume":"84","author":"IA Ebong","year":"2024","unstructured":"Ebong IA, Quesada O, Fonkoue IT et al (2024) The role of psychosocial stress on cardiovascular disease in women: JACC State-of-the-Art Review. J Am Coll Cardiol 84(3):298\u2013314. https:\/\/doi.org\/10.1016\/j.jacc.2024.05.016","journal-title":"J Am Coll Cardiol"},{"key":"10528_CR115","doi-asserted-by":"crossref","unstructured":"Konhilas JP, Leinwand LA (2007) The effects of biological sex and diet on the development of heart failure. Circulation 116:2747\u20132759","DOI":"10.1161\/CIRCULATIONAHA.106.672006"}],"container-title":["Heart Failure Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10741-025-10528-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10741-025-10528-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10741-025-10528-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,6]],"date-time":"2025-09-06T16:17:20Z","timestamp":1757175440000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10741-025-10528-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,30]]},"references-count":115,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2025,9]]}},"alternative-id":["10528"],"URL":"https:\/\/doi.org\/10.1007\/s10741-025-10528-9","relation":{},"ISSN":["1573-7322"],"issn-type":[{"value":"1573-7322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,30]]},"assertion":[{"value":"13 May 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 May 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}